Negative regulation of cytokine signaling by the SOCS proteins

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 64, Issue , 1999, Pages 397-404

  Nicola, N A ^a   Nicholson, S E ^a   Metcalf, D ^a   Zhang, J G ^a   Baca, M ^a   Farley, A ^a   Willson, T A ^a   Starr, R ^a   Alexander, W ^a   Hilton, D J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PROTEIN DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; JANUS KINASE; JANUS KINASE INHIBITOR; RAS PROTEIN; SOMATOMEDIN C RECEPTOR; SONIC HEDGEHOG PROTEIN; SPROUTY PROTEIN; STAT PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; THROMBOPOIETIN; VON HIPPEL LINDAU PROTEIN;

CELL SPECIFICITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DIMERIZATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE CONTROL; GENE DELETION; GENETIC TRANSFORMATION; NEGATIVE FEEDBACK; PROTEIN BINDING; PROTEIN DEGRADATION; SEMLIKI FOREST VIRUS; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

EID: 0033504424     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.1999.64.397     Document Type: Conference Paper

References (43)

1. Adams T.E., Hansen J.A., Starr R., Nicola N.A., Hilton D.J., and Billestrup N. 1998. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 273: 1285.
2. Alexander W.S., Starr R., Fenner J., Scott C.L, Handman E., Sprigg N.S, Corbin J.E., Cornish A.L., Darwiche R., Owczarek C.M., Kay T.W.H., Nicola N.A., Hertzog P.J., Metcalf D., and Hilton D.J. 1999. SOCS-1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98: 597.
3. Auernhammer C.J., Chesnokova V., Bousquet C., and Melmed S. 1998. Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol Endocrinol 12: 954.
4. Bjorbaek C. Elmquist J.K., Frantz J.D., Shoelson S.E., and Flier J. S. 1998. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 1: 619.
5. De Sepulveda P., Okkenhaug K., Rose J.L., Hawley R.G., Dubreuil P., and Rottapel R. 1999. Socs1 binds to multiple signalling proteins and suppresses Steel factor-dependent proliferation. EMBO J. 18: 904.
6. Dey, B.R., Spence S.L., Nissley P., and Furlanetto R.W. 1998. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J. Biol. Chem. 273: 24095.
7. Endo T.A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., and Yoshimura A. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387: 921.
8. Feldman G.M., Rosenthal L.A., Liu X., Hayes M.P., Wynshaw-Boris A., Leonard W.J., Hennighausen L., and Finbloom D.S. 1997. STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90: 1768.
9. Heim M.H. 1999. The Jak-STAT pathway: Cytokine signalling from the receptor to the nucleus. J. Recept. Signal Transduct. Res. 19: 75.
10. Helman D., Sandowski Y., Cohen Y., Matsumoto A., Yoshimura A., Merchav S., and Gertler A. 1998. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling. FEBS Lett. 441: 287.
11. Hilton D.J., Richardson R.T., Alexander W.S., Viney E.M., Willson T.A., Sprigg N.S., Starr R., Nicholson S.E., Metcalf D., and Nicola N.A. 1998. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. 95: 114.
12. Ihle J.N., Thierfelder W., Teglund S., Stravapodis D., Wang D., Feng J., and Parganis E. 1998. Signaling by the cytokine receptor superfamily. Ann. N. Y. Acad. Sci. 865: 1.
13. Kamura T., Sato S., Haque D., Liu L., Kaelin W.G., Jr., Conaway R.C., and Conaway J.W. 1998. The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12: 3872.
14. Kamura T., Koepp D.M., Conrad M.N., Skowyra D., Moreland R.J., Iliopoulos O., Lane W.S., Kaelin W.G., Jr., Elledge S.J., Conaway R.C., Harper J.W., and Conaway J.W. 1999. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284: 657.
15. Leonard W.J. and O'Shea J.J. 1998. Jaks and STATs: Biological implications. Annu. Rev. Immunol. 16: 293.
16. Losman J.A., Chen X.P., Hilton D., and Rothman P. 1999. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. J. Immunol. 162: 3770.
17. Masuhara M., Sakamoto H., Matsumoto A., Suzuki R., Yasukawa H., Mitsui K., Wakioka T., Tanimura S., Sasaki A., Misawa H., Yokouchi M., Ohtsubo M., and Yoshimura A. 1997. Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun. 239: 439.
18. Matsumoto A., Masuhara M., Mitsui K., Yokouchi M., Ohtsubo M., Misawa H., Miyajima A., and Yoshimura A. 1997. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89: 3148.
19. Matuoka K., Miki H., Takahashi K., and Takenawa T. 1997. A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs. Biochem. Biophys. Res. Commun. 239: 488.
20. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., and Ratcliffe P.J. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271.
21. Minamoto S., Ikegame K., Ueno K., Narazaki M., Naka T., Yamamoto H., Matsumoto T., Saito H., Hosoe S., and Kishimoto T. 1997. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochem. Biophys. Res. Commun. 237: 79.
22. Naka T., Matsumoto T., Narazaki M., Fujimoto M., Morita Y., Ohsawa Y., Saito H., Nagasawa T., Uchiyama Y., and Kishimoto T. 1998. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. 95: 15577.
23. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., and Kishimoto T. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387: 924.
24. Narazaki M., Fujimoto M., Matsumoto T., Morita Y., Saito H., Kajita T., Yoshizaki K., Naka T., and Kishimoto T. 1998. Three distinct domains of SSI-1/SOCS-l/JAB protein are required for its suppression of interleukin 6 signaling. Proc. Natl. Acad. Sci. 95: 13130.
25. Nicholson S.E., Willson T.A., Farley A., Starr R., Zhang J.G., Baca M., Alexander W.S., Metcalf D., Hilton D.J., and Nicola N.A. 1999. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18: 375.
26. Nicola N.A., Ed. 1994. Guidebook to cytokines and their receptors. Oxford University Press, Oxford, United Kingdom.
27. Ohya K., Kajigaya S., Yamashita Y., Miyazato A., Hatake K., Miura Y., Ikeda U., Shimada K., Ozawa K., and Mano H. 1997. SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase. J. Biol. Chem. 272: 27178.
28. Sakamoto H., Yasukawa H., Masuhara M., Tanimura S., Sasaki A., Yuge K., Ohtsubo M., Ohtsuka A., Fujita T., Ohta T., Furukawa Y., Iwase S., Yamada H., and Yoshimura A. 1998. A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood 92: 1668.
29. Skowyra D., Koepp D.M., Kamura T., Conrad M.N., Conaway R.C., Conaway J.W., Elledge S.J., and Harper J.W. 1999. Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1. Science 284: 662.
30. Song M.M. and Shuai K. 1998. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273: 35056.
31. Starr R. and Hilton D.J. 1998. SOCS: Suppressors of cytokine signalling. Int. J. Biochem. Cell Biol. 30: 1081.
32. Starr R., Metcalf D., Elefanty A.G., Brysha M., Willson T.A., Nicola N.A., Hilton D.J., and Alexander W.S. 1998. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. 95: 14395.
33. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., and Hilton D.J. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387: 917.
34. Stebbins C.E., Kaelin W.G., Jr., and Pavletich N.P. 1999. Structure of the VHL-ElonginC-ElonginB complex: Implications for VHL tumor suppressor function. Science 284: 455.
35. Suzuki R., Sakamoto H., Yasukawa H., Masuhara M., Wakioka T., Sasaki A., Yuge K., Komiya S., Inoue A., and Yoshimura A. 1998. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells. Oncogene 17: 2271.
36. Vasiliauskas D., Hancock S., and Stern C.D. 1999. SWiP-1: Novel SOCS box containing WD-protein regulated by signalling centres and by Shh during development. Mech. Dev. 82: 79.
37. Verdier F., Chretien S., Muller O., Varlet P., Yoshimura A., Gisselbrecht S., Lacombe C., and Mayeux P. 1998a. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein. J. Biol. Chem. 273: 28185.
38. Verdier F., Rabionet R., Gouilleux F., Beisenherz-Huss C., Varlet P., Muller O., Mayeux P., Lacombe C., Gisselbrecht S., and Chretien S. 1998b. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: A distinct biochemical difference between STAT5A and STAT5B. Mol. Cell. Biol. 18: 5852.
39. Wang D., Stravopodis D., Teglund S., Kitazawa J., and Ihle J.N. 1996. Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16: 6141.
40. Yasukawa H., Misawa H., Sakamoto H., Masuhara M., Sasaki A., Wakioka T., Ohtsuka S., Imaizumi T., Matsuda T., Ihle J.N., and Yoshimura A. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18: 1309.
41. Yoshimura A. 1998. The CIS/JAB family: Novel negative regulators of JAK signaling pathways. Leukemia 12: 1851.
42. Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N.A., Gilbert D.J., Copeland N.G., Hara T., and Miyajima A. 1995. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14: 2816.
43. Zhang J.G., Farley A., Nicholson S.E., Willson T.A., Zugaro L.M., Simpson R.J., Moritz R.L., Cary D., Richardson R., Hausmann G., Kile B.J., Kent S.B., Alexander W.S., Metcalf D., Hilton D.J., Nicola N.A., and Baca M. 1999. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. 96: 2071.